Clinical Trial

Effect of Rosmarinus Officinalis Extract on Oxidative Stress and Inflammatory Biomarkers in Patients With Type 2 Diabetes(T2DM)

Study acronym: T2DM
Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated April 21, 2026 (before its estimated June 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study will evaluate the effects of Rosmarinus officinalis (rosemary) extract on oxidative stress and inflammation in patients with type 2 diabetes. Participants will be randomly assigned to receive either rosemary extract or a placebo for 12 weeks. The study aims to determine whether rosemary extract can improve health markers related to oxidative stress, inflammation, and metabolic function.
Trial Details
NCT Number NCT07541729
Lead Sponsor Universidad Autonoma de Zacatecas
Conditions Type 2 Diabetes Mellitus (T2DM), Oxidative Stress, Inflammation Chronic
Enrollment 40 participants
Start Date 2025-09-20
Primary Completion 2026-06-01 (estimated)
Study Completion 2026-08-17 (estimated)
Updated on ClinicalTrials.gov 2026-04-21